SCI Abstract

search
Risk Stratification, Screening and Treatment of BRAF/MEK Inhibitors-Associated Cardiotoxicity
Risk Stratification, Screening and Treatment of BRAF/MEK Inhibitors-Associated Cardiotoxicity
In this review article we describe the cardiovascular adverse events associated with BRAF and MEK inhibitors as well as th...
CAR T-cell Therapy for Central Nervous System Lymphoma
CAR T-cell Therapy for Central Nervous System Lymphoma
While anti-CD19 CAR T-cell therapy represents a major advance in systemic diffuse large B-cell lymphomas, central nervous ...
Return to Intended Oncological Therapy: State of the Art and Perspectives
Return to Intended Oncological Therapy: State of the Art and Perspectives
Despite advances in surgical procedures, cancer recurrence still affects a substantial proportion of patients for whom sur...
First-Line Therapy in Metastatic, RAS Wild-Type, Left-Sided Colorectal Cancer: Should Everyone Receive Anti-EGFR Therapy?
First-Line Therapy in Metastatic, RAS Wild-Type, Left-Sided Colorectal Cancer: Should Everyone Receive Anti-EGFR Therapy?
This narrative review explores the efficacy and applicability of anti-EGFR therapy as the first-line treatment for patient...
The Difficult Airway in Patients with Cancer
The Difficult Airway in Patients with Cancer
The goal of this review is to provide an overview of difficult airway management in the cancer population. Difficult airwa...
Paediatric Acute Lymphoblastic Leukaemia: A Narrative Review of Current Knowledge and Advancements
Paediatric Acute Lymphoblastic Leukaemia: A Narrative Review of Current Knowledge and Advancements
This review aims to provide an update on current knowledge regarding paediatric acute lymphoblastic leukaemia (ALL), focus...
Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis
Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis
In this review, we discuss which patients with metastatic clear cell renal cell carcinoma (mRCC) may be most suitable for ...
Multiple Options: How to Choose Therapy in Frontline Metastatic Melanoma
Multiple Options: How to Choose Therapy in Frontline Metastatic Melanoma
Given the rapid development of multiple targeted and immune therapies for patients with advanced melanoma, it can be chall...
Management of Localized Melanoma in the Anti-PD-1 Era
Management of Localized Melanoma in the Anti-PD-1 Era
The management of cutaneous melanoma has rapidly progressed over the past decade following the introduction of effective s...
Screening and Testing for Homologous Recombination Repair Deficiency (HRD) in Breast Cancer: an Overview of the Current Global Landscape
Screening and Testing for Homologous Recombination Repair Deficiency (HRD) in Breast Cancer: an Overview of the Current Global Landscape
Homologous recombination repair deficiency (HRD) increases breast cancer susceptibility and influences both prophylactic a...
Perioperative Blood Transfusions and Cancer Progression: A Narrative Review
Perioperative Blood Transfusions and Cancer Progression: A Narrative Review
To examine the most recent evidence about known controversies on the effect of perioperative transfusion on cancer progres...
From Detection to Cure – Emerging Roles for Urinary Tumor DNA (utDNA) in Bladder Cancer
From Detection to Cure – Emerging Roles for Urinary Tumor DNA (utDNA) in Bladder Cancer
This review sought to define the emerging roles of urinary tumor DNA (utDNA) for diagnosis, monitoring, and treatment of b...
Palliative Rehabilitation in Patients with Cancer: Definitions, Structures, Processes and Outcomes
Palliative Rehabilitation in Patients with Cancer: Definitions, Structures, Processes and Outcomes
This review examines the literature on palliative rehabilitation for patients with advanced cancer, focusing on definition...
The Role of Cannabinoids in Advancing Cancer Treatment: Insights from Evidence-Based Medicine
The Role of Cannabinoids in Advancing Cancer Treatment: Insights from Evidence-Based Medicine
This document critically examines the role of cannabinoids in cancer care during an era marked by rapid advancements in on...
Prevention of Ovarian Cancer: Where are We Now and Where are We Going?
Prevention of Ovarian Cancer: Where are We Now and Where are We Going?
To describe current and future strategies to reduce the burden of ovarian cancer through prevention. Current strategies in...
Proton Therapy in The Treatment of Head And Neck Cancers- Review
Proton Therapy in The Treatment of Head And Neck Cancers- Review
Head and neck cancers rank as the seventh most common cancer worldwide, nearly half of which result in death. The most com...
Unveiling the Hidden Links: Periodontal Disease, Fusobacterium Nucleatum, and Cancers
Unveiling the Hidden Links: Periodontal Disease, Fusobacterium Nucleatum, and Cancers
Fusobacterium nucleatum (F. nucleatum), an anaerobic, gram-negative microbe, commonly found in human dental biofilm and th...
Current Status of Partial Laryngeal Surgery for Advanced Laryngeal Cancer: When and Why?
Current Status of Partial Laryngeal Surgery for Advanced Laryngeal Cancer: When and Why?
This paper aims to evaluate the evolution and current status of partial laryngeal surgery in the treatment of advanced lar...
Update on Percutaneous Ablation for Sarcoma
Update on Percutaneous Ablation for Sarcoma
To provide an update on the current state of percutaneous thermal ablation in the treatment of sarcoma. Data continue to a...
Navigating Breast Cancer Oligometastasis and Oligoprogression: Current Landscape and Future Directions
Navigating Breast Cancer Oligometastasis and Oligoprogression: Current Landscape and Future Directions
We examine the potential for curative approaches among metastatic breast cancer (MBC) patients by exploring the recent lit...
Antibody Drug Conjugates in Urological Cancers: A Review of the Current Landscape
Antibody Drug Conjugates in Urological Cancers: A Review of the Current Landscape
Our review delves into the progress across urological malignancies and discusses ongoing challenges and future directions ...
Minimal Residual Disease-Adapted Therapy in Multiple Myeloma: Current Evidence and Opinions
Minimal Residual Disease-Adapted Therapy in Multiple Myeloma: Current Evidence and Opinions
Multiple myeloma (MM) is a biologically heterogeneous malignancy with relatively uniform treatment paradigms. This review ...
Immune Checkpoint Inhibitors in Geriatric Oncology
Immune Checkpoint Inhibitors in Geriatric Oncology
This manuscript will update prior reviews of immune checkpoint inhibitors (ICIs) in light of basic science, translational,...
Current Trends and Challenges of Microbiome Research in Prostate Cancer
Current Trends and Challenges of Microbiome Research in Prostate Cancer
The role of the gut microbiome in prostate cancer is an emerging area of research interest. However, no single causative o...
Novel Clinical Trials and Approaches in the Management of Glioblastoma
Novel Clinical Trials and Approaches in the Management of Glioblastoma
The purpose of this review is to discuss a wide variety of novel therapies recently studied or actively undergoing study i...
Advances in Radionuclide Therapies for Patients with Neuro-endocrine Tumors
Advances in Radionuclide Therapies for Patients with Neuro-endocrine Tumors
To provide insights into the role of peptide receptor radionuclide therapy (PRRT) in patients with advanced neuroendocrine...
Patient Navigation in Cancer Treatment: A Systematic Review
Patient Navigation in Cancer Treatment: A Systematic Review
Patient navigation promotes access to timely treatment of chronic diseases by eliminating barriers to care. Patient naviga...